. 2015 Aug 14;10(4):1460–1466. doi: 10.3892/etm.2015.2681

Table III.

Comparison of T-lymphocyte subgroup distribution prior to and following immunotherapy.

		Time post-immunotherapy (months)

Lymphocyte subset	Pre-immunotherapy	1	3	6	9	12
CD3⁺	0.711	0.000^a	0.371	0.432	0.436	0.462
CD8⁺	0.843	0.115	0.026^a	0.092	0.115	0.774
CD8⁺CD28⁺	0.323	0.004^a	0.036^a	0.873	0.022^a	0.607
NKT	0.793	0.038^a	0.771	0.160	0.038^a	0.004^a
CD8⁺CD28⁻	0.585	0.432	0.777	0.326	0.471	0.948
CD4⁺CD25⁺	0.915	0.544	0.024^b	0.025^b	0.795	0.629
CD4⁺CD8⁺	0.743	0.585	0.008^b	0.065	0.359	0.879
CD4⁺	0.674	0.053	0.027^b	0.278	0.480	0.311
CD3⁺CD16⁺CD56⁺ (NK)	0.647	0.201	0.694	0.875	0.750	0.642
CD19⁺	0.763	0.057	0.817	0.529	0.289	0.706

T lymphocyte subgroup is higher in patients receiving immunotherapy compared with the control group

T lymphocyte subgroup is lower in patients receiving immunotherapy group compared with the control group. NK, natural killer.